Federal Communications Commission Chairman Brendan Carr on Monday vowed to defend the interests of America's technology ...

U.S. President Donald Trump's cancellation of licenses for foreign oil companies to operate in sanctioned Venezuela will ...

It wasn't just the slowdown in the February ISM manufacturing index — down to 50.3 from 50.9 in January — that appeared to send a chill through investors Monday morning. Underlying data served to ...

The statistics show flying remains the safest form of transportation compared with driving or even riding on a train.

Potential cuts to the U.S. AI Safety Institute (AISI) are causing alarm among some in the technology space who fear the ...

Biogen and Stoke partner on zorevunersen for Dravet syndrome, with a Phase 3 trial starting in 2025. Stoke gets $165 million ...

CAMBRIDGE, Mass. & BEDFORD, Mass.--(BUSINESS WIRE)--Biogen Inc. (Nasdaq: BIIB) and Stoke Therapeutics, Inc. (Nasdaq: STOK) today announced a collaboration for the ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Despite a promising season overall, Tottenham youngster Ashley Phillips has endured a difficult few games for Stoke City on loan.

Biogen (BIIB) and Stoke Therapeutics (STOK) announced a collaboration for the development and commercialization of zorevunersen, a potential ...